![Mark G. Cipriano](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark G. Cipriano
Direttore Finanziario/CFO presso Esperas Pharma Inc.
Posizioni attive di Mark G. Cipriano
Società | Posizione | Inizio | Fine |
---|---|---|---|
Esperas Pharma Inc.
![]() Esperas Pharma Inc. Pharmaceuticals: MajorHealth Technology Esperas Pharma, Inc. manufactures and develops pharmaceutical products. The firm is created to develop one compound to proof-of-concept. It plans to develop, to proof-of-concept, a compound originally discovered through one of Lilly’s research and development programs, with the potential to treat certain types of cancers including triple negative breast cancer. The company was founded in 2015 and is headquartered in Montreal, Canada. | Direttore Finanziario/CFO | - | - |
GLWL Research, Inc.
![]() GLWL Research, Inc. Medical/Nursing ServicesHealth Services GLWL Research, Inc. is a medical research laboratory. It develops and proofs compounds for treatment of diabetes where it has developed an investigational compound known as GLWL-01 to treat type-2 diabetes. The company is headquartered in Montreal, Canada. | Direttore Finanziario/CFO | - | - |
Storia della carriera di Mark G. Cipriano
Precedenti posizioni note di Mark G. Cipriano
Società | Posizione | Inizio | Fine |
---|---|---|---|
Transave, Inc.
![]() Transave, Inc. Pharmaceuticals: MajorHealth Technology Transave, Inc. is a biopharmaceutical company focused on developing innovative, inhaled pharmaceuticals for the site-specific treatment of serious lung diseases such as pulmonary infections in cystic fibrosis patients and cancers affecting the lung. They are committed to significantly improving the quality of life and healthcare of patients suffering from these life-threatening diseases. Its operating principles are centered on teamwork, openness, mutual respect, diversity of opinion, trust, accountability and innovative science. They are developing products based on Transave's proprietary liposomal technology designed specifically for lung delivery. Its focus is on reformulating off-patent, established drugs into unique liposomal technology - based inhaled pharmaceuticals for the localized, site-specific treatment of serious lung diseases. Transave's proprietary liposomal technology allows for the sustained release of a drug in the lung's microenvironment. By remaining in the lungs for a prolonged period and potentially minimizing systemic exposure, Transave's liposomal technology offers the potential for changing the product profile, improving delivery of the compound to the lung and enhancing the therapeutic index of established pharmaceuticals. | Direttore/Membro del Consiglio | - | 30/08/2012 |
Ascent Venture Management Inc.
![]() Ascent Venture Management Inc. Investment ManagersFinance Ascent Venture Management Inc (Ascent Venture Partners) is a venture capital firm founded in 1985. The firm is headquartered in Boston, Massachusetts. | Direttore Finanziario/CFO | 01/01/1998 | 31/12/1999 |
PricewaterhouseCoopers LLP
![]() PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Comptroller/Controller/Auditor | - | 31/12/1997 |
RAPID MICRO BIOSYSTEMS, INC. | Direttore/Membro del Consiglio | - | - |
Formazione di Mark G. Cipriano
Suffolk University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Canada | 3 |
Regno Unito | 2 |
Posizioni
Director of Finance/CFO | 3 |
Director/Board Member | 2 |
Comptroller/Controller/Auditor | 1 |
Settori
Health Technology | 3 |
Commercial Services | 2 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
RAPID MICRO BIOSYSTEMS, INC. | Producer Manufacturing |
Aziende private | 5 |
---|---|
PricewaterhouseCoopers LLP
![]() PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
Ascent Venture Management Inc.
![]() Ascent Venture Management Inc. Investment ManagersFinance Ascent Venture Management Inc (Ascent Venture Partners) is a venture capital firm founded in 1985. The firm is headquartered in Boston, Massachusetts. | Finance |
Transave, Inc.
![]() Transave, Inc. Pharmaceuticals: MajorHealth Technology Transave, Inc. is a biopharmaceutical company focused on developing innovative, inhaled pharmaceuticals for the site-specific treatment of serious lung diseases such as pulmonary infections in cystic fibrosis patients and cancers affecting the lung. They are committed to significantly improving the quality of life and healthcare of patients suffering from these life-threatening diseases. Its operating principles are centered on teamwork, openness, mutual respect, diversity of opinion, trust, accountability and innovative science. They are developing products based on Transave's proprietary liposomal technology designed specifically for lung delivery. Its focus is on reformulating off-patent, established drugs into unique liposomal technology - based inhaled pharmaceuticals for the localized, site-specific treatment of serious lung diseases. Transave's proprietary liposomal technology allows for the sustained release of a drug in the lung's microenvironment. By remaining in the lungs for a prolonged period and potentially minimizing systemic exposure, Transave's liposomal technology offers the potential for changing the product profile, improving delivery of the compound to the lung and enhancing the therapeutic index of established pharmaceuticals. | Health Technology |
Esperas Pharma Inc.
![]() Esperas Pharma Inc. Pharmaceuticals: MajorHealth Technology Esperas Pharma, Inc. manufactures and develops pharmaceutical products. The firm is created to develop one compound to proof-of-concept. It plans to develop, to proof-of-concept, a compound originally discovered through one of Lilly’s research and development programs, with the potential to treat certain types of cancers including triple negative breast cancer. The company was founded in 2015 and is headquartered in Montreal, Canada. | Health Technology |
GLWL Research, Inc.
![]() GLWL Research, Inc. Medical/Nursing ServicesHealth Services GLWL Research, Inc. is a medical research laboratory. It develops and proofs compounds for treatment of diabetes where it has developed an investigational compound known as GLWL-01 to treat type-2 diabetes. The company is headquartered in Montreal, Canada. | Health Services |
- Borsa valori
- Insiders
- Mark G. Cipriano
- Esperienza